Live Breaking News & Updates on Protara Therapeutics Inc
Stay updated with breaking news from Protara therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Protara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report) major shareholder Opaleye Management Inc. sold 33,000 shares of the stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $3.06, for a total transaction of $100,980.00. Following the sale, the insider now directly owns 124,250 shares of the company’s […] ....
Protara Therapeutics, Inc. (NASDAQ:TARA) Short Interest Up 158.6% in April modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Protara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 398,300 shares, a growth of 510.9% from the March 31st total of 65,200 shares. Approximately 4.4% of the shares of the company are short sold. Based […] ....
Protara Therapeutics (NASDAQ:TARA – Get Free Report) had its price objective increased by Oppenheimer from $26.00 to $30.00 in a research note issued on Monday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Separately, HC Wainwright restated a “buy” rating and set a $23.00 price objective on shares of Protara Therapeutics […] ....
Protara Therapeutics, Inc. announced that it has reached alignment with the U.S. Food and Drug Administration on a registrational path forward for intravenous Choline Chloride, an investigational. ....